{"raw_mentions": "Compounds tested in the above assay are considered to be active if they exhibit a K<sub>i </sub>of \u226610 \u03bcM.\nPreferred compounds of the present invention have K<sub>i</sub>'s of \u22661 \u03bcM.\nMore preferred compounds of the present invention have K<sub>i</sub>'s of \u22660.1 \u03bcM.\nEven more preferred compounds of the present invention have K<sub>i</sub>'s of \u22660.01 \u03bcM.\nStill more preferred compounds of the present invention have K<sub>i</sub>'s of \u22660.001 \u03bcM.\nUsing the methodology described above, a number of compounds of the present invention were found to exhibit K<sub>i</sub>'s of &lt;10 \u03bcM, thereby confirming the utility of the compounds of the present invention as effective Xa inhibitors."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "Ki", "value": "\u226410", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Ki", "value": "\u22641", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Ki", "value": "\u22640.1", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Ki", "value": "\u22640.01", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Ki", "value": "\u22640.001", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "Xa", "binding_metric": "Ki", "value": "<10", "unit": "\u03bcM", "is_logarithmic": false}]}
{"raw_mentions": "Using the methodology described above, some compounds of this invention were evaluated and found to exhibit a Ki of less than 10 \u03bcM."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "Ki", "value": "<10", "unit": "\u03bcM", "is_logarithmic": false}]}
